Agreement with Maastricht University
Glucox Biotech has signed an agreement with Prof. Harald Schmidt of Maastricht University for further development of Glucox´ lead compound for treatment of ischemic stroke.
It has recently been shown that NOX4 is an effective therapeutic target in acute stroke. Prof. Harald Schmidt and his team have convincingly shown that significant increase in NOX4 activity is a main component in neuronal cell death that occurs in ischemic stroke. Within the collaboration Prof. Schmidt and co-workers will evaluate Glucox’ NOX4 inhibitors for further development into pharmaceuticals that will prevent neuronal cell death in ischemic stroke.
Ref: Radermacher, K., A., et al (2012) Experimental & Translational Stroke Medicine, 4:11 doi: 10.1186/2040-7378-4-11
escape room lista
Hello there, just became aware of your blog through Google,
and found that it’s really informative. I’m going to watch out for brussels.
I’ll appreciate if you continue this in future. Numerous people will be benefited from your writing.
Cheers! Lista escape room
Mercedes I
I like this weblog it’s a master piece! Glad
I detected this on google..
travel guide
I like this website very much, Its a real nice post to read
and incur information. Travel blog